Recombinant Vaccinia virus Envelope phospholipase F13 (F13L)
Recombinant Vaccinia virus Envelope phospholipase F13 (F13L) is a purified Recombinant Protein. Purity: >90% as determined by SDS-PAGE. Host: E. coli. Endotoxin Level: Not Tested. Species: Vaccinia virus (strain IHD-J) (VACV) . Target Name: Envelope phospholipase F13 (F13L) . Accession Number: P26653; F13L. Expression Region: 1-372aa. Tag Info: N-terminal 10xHis-tagged and C-terminal Myc-tagged. Theoretical MW: 49.2kda. Target Synonyms: 37 kDa protein; Envelope protein F13; Palmitoylated EV membrane protein; p37K Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
Recombinant Vaccinia virus Envelope phospholipase F13 (F13L) is a purified Recombinant Protein.
Accession Number
P26653; F13L
Expression Region
1-372aa
Host
E. coli
Target
Envelope phospholipase F13 (F13L)
Conjugation
Unconjugated
Tag
N-Terminal 10xHis-Tagged and C-Terminal Myc-Tagged
Field of Research
Immunology
Endotoxin
Not Tested
Purity
>90% by SDS-PAGE
Activity
Not Tested
Length
Full Length
Reconstitution
Refer to the datasheet/CoA included in the product pouch.
Molecular Weight
49.2kDa
Shipping Conditions
Ice packs
Storage Conditions
-20°C. Avoid repeated freeze/thaw cycles.
Target Alternative Name
37 kDa protein; Envelope protein F13; Palmitoylated EV membrane protein; p37K
Species
Vaccinia virus (strain IHD-J) (VACV)
Protein Name
Recombinant Protein
AA Sequence
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 8/18 (C-51), CF740 conjugate, 0.1mg/mL
CD106 / VCAM1 (1.4C3), CF405S conjugate, 0.1mg/mL
CD45RO (UCHL-1), CF405S conjugate, 0.1mg/mL
